Advertisement
Screener

Horizon Therapeutics Public Ltd Co Debt Conversion, Original Debt, Amount

Horizon Therapeutics Public Ltd Co Debt Conversion, Original Debt, Amount

Horizon Therapeutics Public Ltd Co reported Debt Conversion, Original Debt, Amount of $60.98 million for the 12-month period ending 2015-12-31, per its 10-K filed 2018-02-28.

Discontinued › Cash Flow › Financing Activities

us-gaap:DebtConversionOriginalDebtAmount1 · last filed 2018-02-28

  • Horizon Therapeutics Public Ltd Co debt conversion, original debt, amount for the quarter ending 2015-12-31 was $0.00, a 100.00% decline year-over-year.
  • Horizon Therapeutics Public Ltd Co debt conversion, original debt, amount for the quarter ending 2015-09-30 was $0.00.
  • Horizon Therapeutics Public Ltd Co debt conversion, original debt, amount for the quarter ending 2015-06-30 was $28.44M.
  • Horizon Therapeutics Public Ltd Co debt conversion, original debt, amount for the quarter ending 2015-03-31 was $32.55M.
  • Horizon Therapeutics Public Ltd Co debt conversion, original debt, amount for fiscal 2015 was $60.98M, a 31.49% decline from fiscal 2014.
  • Horizon Therapeutics Public Ltd Co debt conversion, original debt, amount for fiscal 2014 was $89.02M.
Period endDebt Conversion, Original Debt, Amount 3 monthDebt Conversion, Original Debt, Amount 6 monthDebt Conversion, Original Debt, Amount 9 monthDebt Conversion, Original Debt, Amount 12 month
2015-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28
$0.00
derived: sum of 2 quarters · filed 2018-02-28
$28.44M
derived: sum of 3 quarters · filed 2018-02-28
$60.98M
10-K · filed 2018-02-28
2015-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07
$28.44M
derived: sum of 2 quarters · filed 2016-11-07
$60.98M
10-Q · filed 2016-11-07
$89.08B
derived: sum of 4 quarters · filed 2016-11-07
2015-06-30$28.44M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08
$60.98M
10-Q · filed 2016-08-08
$89.08B
derived: sum of 3 quarters · filed 2016-08-08
2015-03-31$32.55M
10-Q · filed 2016-05-09
$89.05B
derived: sum of 2 quarters · filed 2016-05-09
2014-12-31$89.02B
10-K/A · filed 2015-03-02
$89.02M
10-K · filed 2017-02-27